AI-generated summary
The authors report a randomized clinical trial of 16 patients with androgenetic alopecia treated weekly for 24 weeks with a light-guiding microneedle patch under green (522 nm) or red (633 nm) LED light. Both wavelengths were associated with significant increases in hair density and diameter, with no statistically significant difference between them and no serious adverse effects reported.
- Participants
- 16
- Who or what was studied
- Patients with androgenetic alopecia
- Wavelengths
- 522, 633 nm
- Limits stated in the abstract
- The abstract does not describe a control group for comparison with no treatment, and the sample of 16 patients is small.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 522 nm, 633 nm
- Energy density (fluence)
- 40 J/cm2
- Power density (irradiance)
- 50 mW/cm2
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Androgenetic alopecia, Light-emitting diode, LED helmet, Low-level laser therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.